News

Monday, 8. February 2010

Company News: SuppreMol Appoints Dr. Robert Phelps as Head of Business Development & Licensing

SuppreMol GmbH, a privately held biopharmaceutical company developing novel therapeutics for the treatment of autoimmune diseases, today announced that Dr. Robert Phelps has joined the Company as Head of Business Development & Licensing.

See the full release at SupperMol´s website.

Company News: Indivumed to Study the Integrity of Biospecimen Sampling Procedures for the U.S. National Cancer Institute

Food for Thought: An Artificial Tree to Remove CO2 from the Atmosphere